nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00751	0.00751	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00749	0.00749	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00749	0.00749	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00725	0.00725	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00723	0.00723	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.00689	0.00689	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.00687	0.00687	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00677	0.00677	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00649	0.00649	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00649	0.00649	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00641	0.00641	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00641	0.00641	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HCRTR2—narcolepsy	0.00628	0.00628	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HCRTR1—narcolepsy	0.00628	0.00628	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00627	0.00627	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00625	0.00625	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00619	0.00619	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00617	0.00617	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00615	0.00615	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—P2RY11—narcolepsy	0.00606	0.00606	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—HRH3—narcolepsy	0.00566	0.00566	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00535	0.00535	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0053	0.0053	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00525	0.00525	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00523	0.00523	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00521	0.00521	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HCRT—narcolepsy	0.00516	0.00516	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00513	0.00513	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00505	0.00505	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00467	0.00467	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00466	0.00466	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—PENK—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0045	0.0045	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00423	0.00423	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00423	0.00423	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00409	0.00409	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00408	0.00408	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00406	0.00406	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00404	0.00404	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00402	0.00402	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.0038	0.0038	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.0038	0.0038	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00377	0.00377	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00373	0.00373	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00373	0.00373	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00355	0.00355	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00354	0.00354	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00353	0.00353	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0035	0.0035	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00348	0.00348	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00346	0.00346	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00345	0.00345	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00338	0.00338	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00302	0.00302	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.003	0.003	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00265	0.00265	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CHKB—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PENK—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TRH—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CPT1B—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000983	0.000983	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000983	0.000983	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000979	0.000979	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000979	0.000979	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00097	0.00097	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00097	0.00097	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000965	0.000965	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000937	0.000937	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000927	0.000927	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000877	0.000877	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000861	0.000861	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000861	0.000861	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000799	0.000799	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000796	0.000796	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000789	0.000789	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000701	0.000701	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000698	0.000698	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000691	0.000691	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000651	0.000651	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000649	0.000649	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000643	0.000643	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000591	0.000591	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000589	0.000589	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000584	0.000584	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.00058	0.00058	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.00058	0.00058	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000573	0.000573	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000573	0.000573	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000518	0.000518	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000349	0.000349	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000348	0.000348	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000345	0.000345	CbGpPWpGaD
